Quercus Molecular Design, LLC

Avon, CT

UEI
ZHH5N3KV48A5
CAGE
7REH3
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
393 Huckleberry Hill Rd, Avon, CT 06001, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Similar vendors

About the company

Quercus Molecular Design, LLC is a for-profit limited liability company that provides research and development services to the U.S. federal government through grant awards from agencies such as the National Institutes of Health. Quercus specializes in developing therapeutic agents targeting infectious diseases and cancer.

Through past federal grants, Quercus Molecular Design has conducted research and development of antifungal, antibacterial, and antileukemia drug candidates. This includes a recent $300,000 project grant from NIH to develop cryptococcal infection treatments, a $600,000 project grant from NIH to develop therapies for Mycobacterium avium complex infections, a $300,000 NIH grant to develop broad spectrum antifungal agents, and a $300,000 NIH National Cancer Institute grant to develop antimetabolites for acute myeloid leukemias. The company has received funding as a prime recipient from NIH programs including Allergy and Infectious Diseases Research and served as a research partner on infectious disease and cancer therapy development projects.

Quick answers

Is Quercus Molecular Design, LLC registered in SAM.gov?

Yes. Quercus Molecular Design, LLC's SAM.gov registration is active through July 29, 2027.

What is Quercus Molecular Design, LLC's most recent federal award?

Quercus Molecular Design, LLC's most recent federal grant award is Therapeutic agents targeting cryptococcal infections - cryptococcus species are a clinically important group of… (R41AI172564), from National Institute of Allergy and Infectious Diseases (NIH), on March 8, 2023.

On GovTribe

See Quercus Molecular Design, LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors